AU3951389A - The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseases - Google Patents
The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseasesInfo
- Publication number
- AU3951389A AU3951389A AU39513/89A AU3951389A AU3951389A AU 3951389 A AU3951389 A AU 3951389A AU 39513/89 A AU39513/89 A AU 39513/89A AU 3951389 A AU3951389 A AU 3951389A AU 3951389 A AU3951389 A AU 3951389A
- Authority
- AU
- Australia
- Prior art keywords
- boronicacid
- prophylaxis
- alpha
- derivatives
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/553—Renin inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3827340A DE3827340A1 (en) | 1988-08-12 | 1988-08-12 | USE OF (ALPHA) -AMINOBORONIC ACID DERIVATIVES FOR THE PROPHYLAXIS AND TREATMENT OF VIRUS DISEASES |
DE3827340 | 1988-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3951389A true AU3951389A (en) | 1990-03-29 |
Family
ID=6360676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU39513/89A Abandoned AU3951389A (en) | 1988-08-12 | 1989-08-11 | The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseases |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0354522A1 (en) |
JP (1) | JPH0291023A (en) |
KR (1) | KR900002766A (en) |
AU (1) | AU3951389A (en) |
DE (1) | DE3827340A1 (en) |
DK (1) | DK395789A (en) |
IL (1) | IL91276A0 (en) |
NO (1) | NO893240L (en) |
PT (1) | PT91426A (en) |
ZA (1) | ZA896150B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU608379B2 (en) * | 1987-11-05 | 1991-03-28 | Hoechst Aktiengesellschaft | Renin inhibitors |
AU635800B2 (en) * | 1989-12-14 | 1993-04-01 | Chevron Research And Technology Company | Fungicidal imidazole diphenylaliphaticboranes |
AU643312B2 (en) * | 1990-08-13 | 1993-11-11 | Novartis Ag | Improvements in or relating to organic chemistry |
AU666294B2 (en) * | 1990-11-14 | 1996-02-08 | Axis Biochemicals Asa | Labelling agents comprising boronic acid conjugates |
US8859504B2 (en) | 2008-06-17 | 2014-10-14 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US11241448B2 (en) | 2014-05-20 | 2022-02-08 | Millennium Pharmaceuticals, Inc. | Methods for cancer therapy |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5554728A (en) * | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
DE4126485A1 (en) * | 1991-08-10 | 1993-02-11 | Bayer Ag | TRIFLUOROMETHYL-CONTAINING PSEUDOPEPTIDE |
US5693617A (en) * | 1994-03-15 | 1997-12-02 | Proscript, Inc. | Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein |
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
DE4441483C1 (en) * | 1994-11-22 | 1996-04-04 | Gsf Forschungszentrum Umwelt | Use of bio-assimilated boron cpds. |
US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
US7442830B1 (en) | 2007-08-06 | 2008-10-28 | Millenium Pharmaceuticals, Inc. | Proteasome inhibitors |
US7838673B2 (en) | 2007-10-16 | 2010-11-23 | Millennium Pharmaceuticals, Inc. | Proteasome inhibitors |
AR075090A1 (en) | 2008-09-29 | 2011-03-09 | Millennium Pharm Inc | ACID DERIVATIVES 1-AMINO-2-CYCLLOBUTILETILBORONICO PROTEOSOMA INHIBITORS, USEFUL AS ANTI-BANKER AGENTS, AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM. |
EP2516449A1 (en) | 2009-12-22 | 2012-10-31 | Cephalon, Inc. | Proteasome inhibitors and processes for their preparation, purification and use |
US9359398B2 (en) * | 2010-03-01 | 2016-06-07 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
US8513218B2 (en) | 2010-03-31 | 2013-08-20 | Millennium Pharmaceuticals, Inc. | Derivatives of 1-amino-2-cyclopropylethylboronic acid |
CN103483363B (en) * | 2012-06-13 | 2016-12-21 | 上海赛迦化工产品有限公司 | Multifarious chiral aminoboronic acid and its preparation method and application |
CN103396426B (en) * | 2013-07-12 | 2016-09-28 | 上海工程技术大学 | Chirality boronic acid derivatives and its preparation method and application |
CN103408572B (en) * | 2013-07-12 | 2015-12-02 | 上海工程技术大学 | Chiral aminoboronic acid derivative and its preparation method and application |
JP7164521B2 (en) | 2016-06-21 | 2022-11-01 | オリオン・オフサルモロジー・エルエルシー | carbocyclic prolinamide derivatives |
EP4257191A3 (en) | 2016-06-21 | 2023-11-22 | Orion Ophthalmology LLC | Heterocyclic prolinamide derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4537773A (en) * | 1983-12-05 | 1985-08-27 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid derivatives |
US4499082A (en) * | 1983-12-05 | 1985-02-12 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid peptides |
US5187157A (en) * | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
EP0315574A3 (en) * | 1987-11-05 | 1990-08-22 | Hoechst Aktiengesellschaft | Renin inhibitors |
-
1988
- 1988-08-12 DE DE3827340A patent/DE3827340A1/en not_active Withdrawn
-
1989
- 1989-08-08 EP EP89114601A patent/EP0354522A1/en not_active Withdrawn
- 1989-08-10 IL IL91276A patent/IL91276A0/en unknown
- 1989-08-10 PT PT91426A patent/PT91426A/en unknown
- 1989-08-11 DK DK395789A patent/DK395789A/en not_active Application Discontinuation
- 1989-08-11 JP JP1207061A patent/JPH0291023A/en active Pending
- 1989-08-11 AU AU39513/89A patent/AU3951389A/en not_active Abandoned
- 1989-08-11 NO NO89893240A patent/NO893240L/en unknown
- 1989-08-11 ZA ZA896150A patent/ZA896150B/en unknown
- 1989-08-12 KR KR1019890011499A patent/KR900002766A/en not_active Application Discontinuation
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU608379B2 (en) * | 1987-11-05 | 1991-03-28 | Hoechst Aktiengesellschaft | Renin inhibitors |
AU635800B2 (en) * | 1989-12-14 | 1993-04-01 | Chevron Research And Technology Company | Fungicidal imidazole diphenylaliphaticboranes |
AU643312B2 (en) * | 1990-08-13 | 1993-11-11 | Novartis Ag | Improvements in or relating to organic chemistry |
AU666294B2 (en) * | 1990-11-14 | 1996-02-08 | Axis Biochemicals Asa | Labelling agents comprising boronic acid conjugates |
US8859504B2 (en) | 2008-06-17 | 2014-10-14 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US9175018B2 (en) | 2008-06-17 | 2015-11-03 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US9175017B2 (en) | 2008-06-17 | 2015-11-03 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US10526351B2 (en) | 2008-06-17 | 2020-01-07 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US10604538B2 (en) | 2008-06-17 | 2020-03-31 | Millenium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US11485746B2 (en) | 2008-06-17 | 2022-11-01 | Millennium Pharmaceuticals, Inc. | Boronate ester compounds and pharmaceutical compositions thereof |
US11241448B2 (en) | 2014-05-20 | 2022-02-08 | Millennium Pharmaceuticals, Inc. | Methods for cancer therapy |
Also Published As
Publication number | Publication date |
---|---|
KR900002766A (en) | 1990-03-31 |
JPH0291023A (en) | 1990-03-30 |
ZA896150B (en) | 1991-01-30 |
DE3827340A1 (en) | 1990-02-15 |
EP0354522A1 (en) | 1990-02-14 |
IL91276A0 (en) | 1990-03-19 |
DK395789D0 (en) | 1989-08-11 |
DK395789A (en) | 1990-02-13 |
NO893240L (en) | 1990-03-27 |
NO893240D0 (en) | 1989-08-11 |
PT91426A (en) | 1990-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3951389A (en) | The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseases | |
AU4205789A (en) | Method and composition for the treatment and prevention of viral infections | |
AU674894B2 (en) | Treatment of conditions and disease | |
AU2845492A (en) | Dipyridamole for the treatment of proliferative diseases | |
AU6613990A (en) | Thiazolidine derivatives for the treatment of hypertension | |
AU7549787A (en) | Isoliquiritigenin for the treatment of kidney and liver diseases | |
AU3066789A (en) | Optically pure r-(-)-niguldipine and its derivatives for treating tumorous diseases | |
AU617187B2 (en) | Treatment of aqueous dispersions | |
ZA835360B (en) | Use of sugar derivatives for the prophylaxis and treatment of virus infections | |
AU6527390A (en) | Pharmaceutical compositions for the treatment of ataxy and equilibrium problems | |
AU3434489A (en) | Skin treatment formulations | |
IL97734A0 (en) | Benzoxazine derivatives,process for their preparation and their use for treatment or for the prophylaxis of diseases | |
AU3579189A (en) | Acyl carnitine for the treatment and prevention of virus infections | |
EP0343671A3 (en) | Pharmaceutical composition for the treatment of skin wounds | |
AU4819993A (en) | Drug for treatment and prophylaxis of bone and joint diseases | |
AU4829190A (en) | Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections | |
AU8083591A (en) | Therapy and prophylaxis of autoimmune diseases | |
EP0407788A3 (en) | Use of retinoids for the treatment and prophylaxis of immune related diseases | |
GB2220652B (en) | Treatment of pastures | |
IL82702A0 (en) | Use of avarone and avarol and derivatives thereof for the control of aids and arc | |
AU4757293A (en) | Procedure for the treatment and shaping of hair | |
AU4023889A (en) | Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases | |
AU7078691A (en) | Use of urapidile and derivatives for treating arteriosclerotic diseases | |
AU6149690A (en) | Tetrahydrobenzothiazole derivatives for treating diseases of the eye | |
EP0343258A4 (en) | Agent for prophylaxis and treatment of virally infected diseases. |